Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kenvue urges US FDA to deny request for Tylenol's autism warning
12:35pm, Monday, 20'th Oct 2025
Kenvue has urged U.S. regulators to reject a request for a warning of autism on its popular over-the-counter pain medication Tylenol for use during pregnancy, according to a petition.
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
01:25pm, Sunday, 19'th Oct 2025
Kenvue (KVUE 8.43%) isn't a household name. The consumer health products company has been around in its current form for only a couple of years.
What Moved Markets This Week
07:17am, Saturday, 18'th Oct 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
September Readers ID'd 17 Ideal 'Safer' Dividends In 39 Dogs
05:54pm, Friday, 17'th Oct 2025
This article highlights top ReFa/Ro dividend stocks for September 2025, focusing on high yield and analyst-projected returns through September 2026. MFA Financial, Hafnia, and Energy Transfer lead the
Top Stock Movers Now: Oracle, Newmont, Kenvue, American Express, and More
01:20pm, Friday, 17'th Oct 2025
Major U.S. equities indexes climbed at midday Friday as regional bank stocks rebounded from yesterday's losses after a flurry of corporate earnings reports. The Dow, S&P 500, and Nasdaq were all highe
Why Kenvue Stock Tumbled by 13% on Thursday
06:06pm, Thursday, 16'th Oct 2025
A potential legal headache for consumer healthcare giant Kenvue (KVUE -13.50%) was causing pain for investors on Thursday. Such troubles tend to spook the market; hence the more than 13% sell-off of K
S&P 500 Gains and Losses Today: Regional Banks Slump on Worries About Bad Loans; Data Storage Stocks Surge
05:45pm, Thursday, 16'th Oct 2025
Reports of elevated loan losses from regional banks weighed on the sector, while expectations of AI-driven growth helped lift shares of companies in the data storage and memory chip businesses.
Kenvue: A Rock Solid 5% Yield
08:45am, Wednesday, 15'th Oct 2025
Kenvue offers stable financials, a robust 5% dividend yield, and the stock trades at a significant discount to peers and historical averages. KVUE's recent decline, driven by Tylenol-related headlines
Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI
12:00pm, Tuesday, 14'th Oct 2025
SUMMIT, N.J. & OAKLAND, Calif.--(BUSINESS WIRE)--Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec�
Trump's Tylenol claims limit M&A options for parent company Kenvue
06:05am, Tuesday, 14'th Oct 2025
Tylenol maker Kenvue was already having a painful year before U.S. President Donald Trump and his health secretary got involved.
Is This Beaten-Down Dividend King a Buy?
04:19am, Friday, 10'th Oct 2025
In today's uncertain economic environment, investing in robust dividend stocks can be a great hedge. Companies that can consistently issue growing payouts tend to have strong underlying businesses cap
Buy 2 Ideal Dividend Kings Of 25 'Safer' In October's 56
12:51am, Friday, 10'th Oct 2025
This October's Dividend Kings list features 56 stocks, with Kenvue and United Bankshares meeting the ideal "fair price" yield criteria. Analysts project the top-ten Dividend Kings could deliver 19.2%
US Republicans and Democrats split on party lines on Trump's Tylenol-autism claim, KFF poll finds
10:58am, Thursday, 09'th Oct 2025
Republicans and Democrats are divided along party lines as to whether they believe the U.S. government's claim that women who take Tylenol during pregnancy are raising the risk of autism in their unbo
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump
09:13am, Wednesday, 08'th Oct 2025
It's fun to follow stocks that soared recently, and it can be sobering to see which ones have plunged -- especially if you're a shareholder. So here's a look at the worst-performing stocks in the S&P
Near 52-Week Low, Should You Buy Kenvue Stock?
05:45am, Wednesday, 08'th Oct 2025
Investors are wondering if the recent weakness in Kenvue (KVUE 3.28%) stock is a buying opportunity for long-term buyers.
